Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Aflibercept
Related studies linked through entity extraction aliases.
Intravitreal Aflibercept Injection for Radiation Retinopathy Trial
- Status
- UNKNOWN
- Phase
- PHASE2
mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME.
- Status
- WITHDRAWN
- Phase
- PHASE4
Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy
- Status
- COMPLETED
- Phase
- PHASE2
Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)
- Status
- UNKNOWN
- Phase
- PHASE4
PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept
- Status
- UNKNOWN
- Phase
- PHASE4
Aflibercept in Recurrent or Persistent CNV
- Status
- RECRUITING
- Phase
- N/A
Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study
- Status
- COMPLETED
- Phase
- PHASE2
Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study
- Status
- UNKNOWN
- Phase
- PHASE4
Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE4
Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis
- Status
- COMPLETED
- Phase
- PHASE3
Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE4
Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioN
- Status
- UNKNOWN
- Phase
- PHASE2
Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
Short-term Efficacy of Intravitreal Afilibercept Depending on Subtypes of Polypoidal Choroidal Vasculopathy: Polypoidal Choroidal Neovascularization or Idiopathic Choroidal Vasculopathy
- Status
- UNKNOWN
- Phase
- N/A
Role of Intravitreal Aflibercept Injection for the Treatment of Radiation Maculopathy
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID).
- Status
- WITHDRAWN
- Phase
- PHASE2